Akshaya Bio Inc. Therapeutic and Overview Pipeline Review H2


Akshaya Bio Inc. Treatment Pipeline Review H2 2016

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development by Akshaya Bio Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/740537-akshaya-bio-inc-product-pipeline-review-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

– The report provides a snapshot of the pipeline therapeutic landscape of Akshaya Bio Inc.
– The report provides overview of Akshaya Bio Inc. including its business description, key facts, and locations and subsidiaries
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report assesses Akshaya Bio Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report features Akshaya Bio Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy
– Evaluate Akshaya Bio Inc.’s strategic position with total access to detailed information on its product pipeline
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Akshaya Bio Inc.
– Identify potential new clients or partners in the target demographic
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Akshaya Bio Inc.’s pipeline depth and focus of pipeline therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Akshaya Bio Inc. Snapshot 5
Akshaya Bio Inc. Overview 5
Key Facts 5
Akshaya Bio Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Akshaya Bio Inc. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Pipeline Products – Combination Treatment Modalities 10
Akshaya Bio Inc. – Pipeline Products Glance 11
Akshaya Bio Inc. – Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Akshaya Bio Inc. – Drug Profiles 13
hepatitis C vaccine – Drug Profile 13
Product Description 13
Mechanism Of Action 13
R&D Progress 13
HIV vaccine – Drug Profile 14
Product Description 14
Mechanism Of Action 14
R&D Progress 14
influenza [strains A/H5N1 + A/H1N1] vaccine – Drug Profile 15
Product Description 15
Mechanism Of Action 15
R&D Progress 15
malaria vaccine – Drug Profile 16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
NU-500 – Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
Vaccine to Target CA9 for Cancer – Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
Vaccine to Target CEA for Oncology – Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
Vaccine to Target HER 2/neu for Cancer – Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
Vaccine to Target MUC1 for Oncology – Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
Vaccine to Target PAP for Prostate Cancer – Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
Westrern Equine Encephalitis Virus Vaccine – Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
Akshaya Bio Inc. – Pipeline Analysis 24
Akshaya Bio Inc. – Pipeline Products by Target 24
Akshaya Bio Inc. – Pipeline Products by Molecule Type 26
Akshaya Bio Inc. – Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
Coverage 28

Access Report @ https://www.wiseguyreports.com/reports/740537-akshaya-bio-inc-product-pipeline-review-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR